Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial

Akihiro Ito,Ichiro Shintaku,Makoto Satoh,Naomasa Ioritani,Masataka Aizawa,Tatsuo Tochigi,Sadafumi Kawamura,Hiroshi Aoki,Isao Numata,Atsushi Takeda,Shunichi Namiki,Takashige Namima,Yoshihiro Ikeda,Koichi Kambe,Atsushi Kyan,Seiji Ueno,Kazuhiko Orikasa,Shinnosuke Katoh,Hisanobu Adachi,Satoru Tokuyama,Shigeto Ishidoya,Takuhiro Yamaguchi,Yoichi Arai

Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial

2013

Purpose We evaluated the efficacy of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma (UUT-UC).

Keywords:

Urology
Carcinoma
Pirarubicin
Physical therapy
Surgery
Medicine
Urinary system
Cystoscopy
upper urinary tract
Ureter
Prospective cohort study
Urinary tract surgery
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

145

Citations